Health hazard evaluation report: HETA-87-412-L2054, Lederle Laboratories, Pearl River, New York.
Authors
Seitz T; Baron S
Source
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 87-412-L2054, 1990 Jul; :1-7
In response to a request from the International Chemical Workers Union, a visit was made to Lederle Laboratories, Pearl River, New York, to investigate possible hazardous working conditions at that site. Workers were concerned over two women who had worked with Thiotepa (52244), a cancer chemotherapeutic agent, and given birth to children with similar heart defects. Approximately 50 workers were involved in the packaging of Thiotepa. A site visit and medical interviews with employees were conducted. Observations during the site visit raised some concerns, including the potential for exposure to Thiotepa powder and vapor, the adequacy of existing personal protective equipment, the poor adherence to the appropriate use of personal protective equipment during clean up operations, the performance of quality control duties in an area where other unprotected workers were located, the lack of a barrier separating the Thiotepa capping area and the adjacent hallway, and the potential for reproductive toxicity. Thiotepa was found to exist in the air at room temperature in both particulate and vapor phases. It was not possible to determine whether the birth defects were caused by exposure to Thiotepa. The authors recommend specific measures to reduce exposure to Thiotepa.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.